NCT01077284View on ClinicalTrials.gov

Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate Stones

PHASE2CompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
HyperuricosuriaKidney Stones
Interventions
DRUG

Febuxostat

Febuxostat capsules

DRUG

Allopurinol

Allopurinol capsules

DRUG

Placebo

Placebo-matching capsules

Trial Locations (28)

Unknown

Birmingham

Anchorage

Tucson

Costa Mesa

Orange

Palmdale

Poway

Rancho Cucamonga

San Diego

Santa Ana

Denver

New Britain

Miami

Augusta

Honolulu

Boise

Meridian

Lexington

Kalamazoo

Jackson

Albuquerque

New Windsor

Shelby

Wilmington

East Providence

Dallas

Houston

Sugar Land

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY